Health · Medical Research · 2 hrs ago
Tissue and Liquid Biopsies May Complement Each Other in Prostate Cancer
Researchers analyzed patients with metastatic castration-resistant prostate cancer, a form of prostate cancer that has spread and no longer responds to hormone-lowering treatment.
The findings were presented at the European Society for Medical Oncology congress.
The analysis compared actionable genomic alterations, changes in cancer genes that may be relevant to treatment decisions.
It found no statistically significant differences in those alterations.
The findings suggest tissue and liquid biopsies may complement each other when examining this cancer.
The available information does not say what further research or clinical steps are planned.
An analysis of patients with metastatic castration-resistant prostate cancer found no statistically significant differences in actionable genomic alterations.
The findings suggest tissue and liquid biopsies may complement each other in prostate cancer.
The analysis was presented at the European Society for Medical Oncology congress.
The report was published by MedPage Today on November 17, 2026.
- Who
- Patients with metastatic castration-resistant prostate cancer.
- What
- An analysis found no statistically significant differences in actionable genomic alterations.
- When
- The report was published on November 17, 2026. The presentation date is not stated.
- Where
- The analysis was presented at the European Society for Medical Oncology congress. The congress location is not stated.
- Why
- Not stated
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- Cancer type
- Metastatic castration-resistant prostate cancer
- Finding
- No statistically significant differences in actionable genomic alterations
- Presentation
- European Society for Medical Oncology congress
- Publication date
- November 17, 2026